Fagron SA (ARSUF)
18.59
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Fagron Price to Book Value: 2.647 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.647 |
| May 02, 2024 | 2.647 |
| May 01, 2024 | 2.647 |
| April 30, 2024 | 2.647 |
| April 29, 2024 | 2.647 |
| April 26, 2024 | 2.647 |
| April 25, 2024 | 2.647 |
| April 24, 2024 | 2.647 |
| April 23, 2024 | 2.647 |
| April 22, 2024 | 2.647 |
| April 19, 2024 | 2.647 |
| April 18, 2024 | 2.647 |
| April 17, 2024 | 2.647 |
| April 16, 2024 | 2.647 |
| April 15, 2024 | 2.647 |
| April 12, 2024 | 2.647 |
| April 11, 2024 | 2.647 |
| April 10, 2024 | 2.647 |
| April 09, 2024 | 2.647 |
| April 08, 2024 | 2.647 |
| April 05, 2024 | 2.647 |
| April 04, 2024 | 2.647 |
| April 03, 2024 | 2.647 |
| April 02, 2024 | 2.647 |
| April 01, 2024 | 2.647 |
| Date | Value |
|---|---|
| March 28, 2024 | 2.647 |
| March 27, 2024 | 2.647 |
| March 26, 2024 | 2.647 |
| March 25, 2024 | 2.647 |
| March 22, 2024 | 2.647 |
| March 21, 2024 | 2.719 |
| March 20, 2024 | 2.719 |
| March 19, 2024 | 2.719 |
| March 18, 2024 | 2.719 |
| March 15, 2024 | 2.719 |
| March 14, 2024 | 2.719 |
| March 13, 2024 | 2.719 |
| March 12, 2024 | 2.719 |
| March 11, 2024 | 2.733 |
| March 08, 2024 | 2.741 |
| March 07, 2024 | 2.741 |
| March 06, 2024 | 2.741 |
| March 05, 2024 | 2.741 |
| March 04, 2024 | 2.741 |
| March 01, 2024 | 2.741 |
| February 29, 2024 | 2.741 |
| February 28, 2024 | 2.741 |
| February 27, 2024 | 2.741 |
| February 26, 2024 | 2.741 |
| February 23, 2024 | 2.741 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.268
Minimum
Jan 03 2023
7.229
Maximum
Oct 01 2020
4.082
Average
3.429
Median
Jan 25 2022
Price to Book Value Benchmarks
| uniQure NV | 1.080 |
| ProQR Therapeutics NV | 3.574 |
| Merus NV | 7.916 |
| argenx SE | 5.630 |
| Pharming Group | 3.078 |
Price to Book Value Related Metrics
| PE Ratio | 17.69 |
| PS Ratio | 1.642 |
| PEG Ratio | 2.588 |
| Price to Free Cash Flow | 14.58 |
| Price | 18.59 |
| Earnings Yield | 5.65% |
| Market Cap | 1.357B |
| PEGY Ratio | 2.133 |
| Operating PE Ratio | 11.11 |
| Normalized PE Ratio | 17.69 |